Report cover image

Global Sorafenib Tosylate Tablets Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 90 Pages
SKU # APRC20354920

Description

Summary

According to APO Research, The global Sorafenib Tosylate Tablets market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Sorafenib Tosylate Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Sorafenib Tosylate Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Sorafenib Tosylate Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Sorafenib Tosylate Tablets include Cipla, Bayer, Beijing Yabao Biological Pharmaceutical Co., Ltd., Jiangxi Shanxiang Pharmaceutical Co., Ltd., CSPC Ouyi Pharmaceutical Co., Ltd. and Chongqing Yaoyou Pharmaceutical Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sorafenib Tosylate Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sorafenib Tosylate Tablets.

The Sorafenib Tosylate Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sorafenib Tosylate Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Sorafenib Tosylate Tablets Segment by Company

Cipla
Bayer
Beijing Yabao Biological Pharmaceutical Co., Ltd.
Jiangxi Shanxiang Pharmaceutical Co., Ltd.
CSPC Ouyi Pharmaceutical Co., Ltd.
Chongqing Yaoyou Pharmaceutical Co., Ltd.

Sorafenib Tosylate Tablets Segment by Type

60 Pieces/Box
120 Pieces/Box
Others

Sorafenib Tosylate Tablets Segment by Application

Online Sale
Pharmacy
Hospital
Others

Sorafenib Tosylate Tablets Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sorafenib Tosylate Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sorafenib Tosylate Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sorafenib Tosylate Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sorafenib Tosylate Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Sorafenib Tosylate Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Table of Contents

90 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Sorafenib Tosylate Tablets Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Sorafenib Tosylate Tablets Sales Estimates and Forecasts (2020-2031)
1.3 Sorafenib Tosylate Tablets Market by Type
1.3.1 60 Pieces/Box
1.3.2 120 Pieces/Box
1.3.3 Others
1.4 Global Sorafenib Tosylate Tablets Market Size by Type
1.4.1 Global Sorafenib Tosylate Tablets Market Size Overview by Type (2020-2031)
1.4.2 Global Sorafenib Tosylate Tablets Historic Market Size Review by Type (2020-2025)
1.4.3 Global Sorafenib Tosylate Tablets Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Sorafenib Tosylate Tablets Sales Breakdown by Type (2020-2025)
1.5.2 Europe Sorafenib Tosylate Tablets Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Sorafenib Tosylate Tablets Sales Breakdown by Type (2020-2025)
1.5.4 South America Sorafenib Tosylate Tablets Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Sorafenib Tosylate Tablets Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Sorafenib Tosylate Tablets Industry Trends
2.2 Sorafenib Tosylate Tablets Industry Drivers
2.3 Sorafenib Tosylate Tablets Industry Opportunities and Challenges
2.4 Sorafenib Tosylate Tablets Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Sorafenib Tosylate Tablets Revenue (2020-2025)
3.2 Global Top Players by Sorafenib Tosylate Tablets Sales (2020-2025)
3.3 Global Top Players by Sorafenib Tosylate Tablets Price (2020-2025)
3.4 Global Sorafenib Tosylate Tablets Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Sorafenib Tosylate Tablets Major Company Production Sites & Headquarters
3.6 Global Sorafenib Tosylate Tablets Company, Product Type & Application
3.7 Global Sorafenib Tosylate Tablets Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Sorafenib Tosylate Tablets Market CR5 and HHI
3.8.2 Global Top 5 and 10 Sorafenib Tosylate Tablets Players Market Share by Revenue in 2024
3.8.3 2023 Sorafenib Tosylate Tablets Tier 1, Tier 2, and Tier 3
4 Sorafenib Tosylate Tablets Regional Status and Outlook
4.1 Global Sorafenib Tosylate Tablets Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Sorafenib Tosylate Tablets Historic Market Size by Region
4.2.1 Global Sorafenib Tosylate Tablets Sales in Volume by Region (2020-2025)
4.2.2 Global Sorafenib Tosylate Tablets Sales in Value by Region (2020-2025)
4.2.3 Global Sorafenib Tosylate Tablets Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Sorafenib Tosylate Tablets Forecasted Market Size by Region
4.3.1 Global Sorafenib Tosylate Tablets Sales in Volume by Region (2026-2031)
4.3.2 Global Sorafenib Tosylate Tablets Sales in Value by Region (2026-2031)
4.3.3 Global Sorafenib Tosylate Tablets Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Sorafenib Tosylate Tablets by Application
5.1 Sorafenib Tosylate Tablets Market by Application
5.1.1 Online Sale
5.1.2 Pharmacy
5.1.3 Hospital
5.1.4 Others
5.2 Global Sorafenib Tosylate Tablets Market Size by Application
5.2.1 Global Sorafenib Tosylate Tablets Market Size Overview by Application (2020-2031)
5.2.2 Global Sorafenib Tosylate Tablets Historic Market Size Review by Application (2020-2025)
5.2.3 Global Sorafenib Tosylate Tablets Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Sorafenib Tosylate Tablets Sales Breakdown by Application (2020-2025)
5.3.2 Europe Sorafenib Tosylate Tablets Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Sorafenib Tosylate Tablets Sales Breakdown by Application (2020-2025)
5.3.4 South America Sorafenib Tosylate Tablets Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Sorafenib Tosylate Tablets Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Cipla
6.1.1 Cipla Comapny Information
6.1.2 Cipla Business Overview
6.1.3 Cipla Sorafenib Tosylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Cipla Sorafenib Tosylate Tablets Product Portfolio
6.1.5 Cipla Recent Developments
6.2 Bayer
6.2.1 Bayer Comapny Information
6.2.2 Bayer Business Overview
6.2.3 Bayer Sorafenib Tosylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bayer Sorafenib Tosylate Tablets Product Portfolio
6.2.5 Bayer Recent Developments
6.3 Beijing Yabao Biological Pharmaceutical Co., Ltd.
6.3.1 Beijing Yabao Biological Pharmaceutical Co., Ltd. Comapny Information
6.3.2 Beijing Yabao Biological Pharmaceutical Co., Ltd. Business Overview
6.3.3 Beijing Yabao Biological Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Beijing Yabao Biological Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Product Portfolio
6.3.5 Beijing Yabao Biological Pharmaceutical Co., Ltd. Recent Developments
6.4 Jiangxi Shanxiang Pharmaceutical Co., Ltd.
6.4.1 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Comapny Information
6.4.2 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Business Overview
6.4.3 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Product Portfolio
6.4.5 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Recent Developments
6.5 CSPC Ouyi Pharmaceutical Co., Ltd.
6.5.1 CSPC Ouyi Pharmaceutical Co., Ltd. Comapny Information
6.5.2 CSPC Ouyi Pharmaceutical Co., Ltd. Business Overview
6.5.3 CSPC Ouyi Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CSPC Ouyi Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Product Portfolio
6.5.5 CSPC Ouyi Pharmaceutical Co., Ltd. Recent Developments
6.6 Chongqing Yaoyou Pharmaceutical Co., Ltd.
6.6.1 Chongqing Yaoyou Pharmaceutical Co., Ltd. Comapny Information
6.6.2 Chongqing Yaoyou Pharmaceutical Co., Ltd. Business Overview
6.6.3 Chongqing Yaoyou Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Chongqing Yaoyou Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Product Portfolio
6.6.5 Chongqing Yaoyou Pharmaceutical Co., Ltd. Recent Developments
7 North America by Country
7.1 North America Sorafenib Tosylate Tablets Sales by Country
7.1.1 North America Sorafenib Tosylate Tablets Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Sorafenib Tosylate Tablets Sales by Country (2020-2025)
7.1.3 North America Sorafenib Tosylate Tablets Sales Forecast by Country (2026-2031)
7.2 North America Sorafenib Tosylate Tablets Market Size by Country
7.2.1 North America Sorafenib Tosylate Tablets Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Sorafenib Tosylate Tablets Market Size by Country (2020-2025)
7.2.3 North America Sorafenib Tosylate Tablets Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Sorafenib Tosylate Tablets Sales by Country
8.1.1 Europe Sorafenib Tosylate Tablets Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Sorafenib Tosylate Tablets Sales by Country (2020-2025)
8.1.3 Europe Sorafenib Tosylate Tablets Sales Forecast by Country (2026-2031)
8.2 Europe Sorafenib Tosylate Tablets Market Size by Country
8.2.1 Europe Sorafenib Tosylate Tablets Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Sorafenib Tosylate Tablets Market Size by Country (2020-2025)
8.2.3 Europe Sorafenib Tosylate Tablets Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Sorafenib Tosylate Tablets Sales by Country
9.1.1 Asia-Pacific Sorafenib Tosylate Tablets Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Sorafenib Tosylate Tablets Sales by Country (2020-2025)
9.1.3 Asia-Pacific Sorafenib Tosylate Tablets Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Sorafenib Tosylate Tablets Market Size by Country
9.2.1 Asia-Pacific Sorafenib Tosylate Tablets Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Sorafenib Tosylate Tablets Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Sorafenib Tosylate Tablets Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Sorafenib Tosylate Tablets Sales by Country
10.1.1 South America Sorafenib Tosylate Tablets Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Sorafenib Tosylate Tablets Sales by Country (2020-2025)
10.1.3 South America Sorafenib Tosylate Tablets Sales Forecast by Country (2026-2031)
10.2 South America Sorafenib Tosylate Tablets Market Size by Country
10.2.1 South America Sorafenib Tosylate Tablets Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Sorafenib Tosylate Tablets Market Size by Country (2020-2025)
10.2.3 South America Sorafenib Tosylate Tablets Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Sorafenib Tosylate Tablets Sales by Country
11.1.1 Middle East and Africa Sorafenib Tosylate Tablets Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Sorafenib Tosylate Tablets Sales by Country (2020-2025)
11.1.3 Middle East and Africa Sorafenib Tosylate Tablets Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Sorafenib Tosylate Tablets Market Size by Country
11.2.1 Middle East and Africa Sorafenib Tosylate Tablets Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Sorafenib Tosylate Tablets Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Sorafenib Tosylate Tablets Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Sorafenib Tosylate Tablets Value Chain Analysis
12.1.1 Sorafenib Tosylate Tablets Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Sorafenib Tosylate Tablets Production Mode & Process
12.2 Sorafenib Tosylate Tablets Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Sorafenib Tosylate Tablets Distributors
12.2.3 Sorafenib Tosylate Tablets Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.